Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Streamlining and Strengthening the Relationship Between Doctors and Pharmaceutical Representatives with Dr. Asher Eghbali Fuerte TRANSCRIPT

Download PDF

Dec 15, 2025

Dr. Asher Eghbali, Co-Founder of Fuerte, has developed a platform to address the significant communication challenges between healthcare providers and pharmaceutical industry representatives. The goal is to streamline this relationship by replacing inefficient scheduling methods, and eliminate miscommunication and...

Streamlining and Strengthening the Relationship Between Doctors and Pharmaceutical Representatives with Dr. Asher Eghbali Fuerte

Dec 15, 2025

Advancement in Abuse-Deterrent Opioids with Paul Howe Protega Pharmaceuticals TRANSCRIPT

Download PDF

Sep 9, 2025

Paul Howe, COO of Protega Pharmaceuticals, is focused on how abuse-deterrent technology can address the opioid crisis and the need for mandates for insurance coverage of safer abuse-deterrent formulations. The SentryBond technology was specifically designed for immediate-release opioids to make it difficult to...

Advancement in Abuse-Deterrent Opioids with Paul Howe Protega Pharmaceuticals

Sep 9, 2025

AI Revolutionizing Drug Development Regulatory Documentation and FDA Submission with Lindsay Mateo Weave TRANSCRIPT

Download PDF

Sep 5, 2025

Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies. The regulatory lifecycle for drug development currently involves data from various sources in...